Abiakam NS (2023) Detecting early signs of skin damage using non-invasive biophysical parameters. University of Southampton
Ackermann L, Harvima I (1998) Mast cells of psoriatic and atopic dermatitis skin are positive for TNF-α and their degranulation is associated with expression of ICAM-1 in the epidermis. Arch Dermatol Res 290:353–359
Afshari M, Kolackova M, Rosecka M, Čelakovská J, Krejsek J (2024) Unraveling the skin; a comprehensive review of atopic dermatitis, current understanding, and approaches. Front Immunol 15:1361005
CAS PubMed PubMed Central Google Scholar
Agrawal R, Woodfolk JA (2014) Skin barrier defects in atopic dermatitis. Curr Allergy Asthma Rep 14:1–11
Ahn YM, Shin S, Jang J-H, Jung J (2023) Bojungikgi-tang improves skin barrier function and immune response in atopic dermatitis mice fed a low aryl hydrocarbon receptor ligand diet. Chin Med 18:100
CAS PubMed PubMed Central Google Scholar
Akdiş M (2009) Mechanisms of allergic inflammation. Güncel Pediatri 7:24–30
Akkoc T, de Koning PJ, Rückert B, Barlan I, Akdis M, Akdis CA (2008) Increased activation-induced cell death of high IFN-γ–producing TH1 cells as a mechanism of TH2 predominance in atopic diseases. J Allergy Clin Immunol 121:652-658.e1
Alyoussef A (2018) Blocking TGF-β type 1 receptor partially reversed skin tissue damage in experimentally induced atopic dermatitis in mice. Cytokine 106:45–53
Anderson ZT (2021) The pathomechanistic role of neuropeptide Y in the skin: overexpression of NPY induces chronic inflammation and skin pathology. The University of Alabama, Birmingham
Anderson ZT, Dawson AD, Slominski AT, Harris ML (2022) Current insights into the role of neuropeptide Y in skin physiology and pathology. Front Endocrinol 13:838434
Arndt J, Smith N, Tausk F (2008) Stress and atopic dermatitis. Curr Allergy Asthma Rep 8:312–317
Atmakuri S, Nene S, Jain H, Joga R, Devabattula G, Godugu C, Srivastava S (2023) Topical delivery of tofacitinib citrate loaded novel nanoemulgel for the management of 2, 4-dichlorodinitrobenzene induced atopic dermatitis in mice model. J Drug Deliv Sci Technol 80:104145
Au S, Levin A, Gottlieb A (2014) Auto-Immunity & Inflammation Psoriasis drug failure rates of biologics compared to conventional systemic therapies
Back SK, Jeong K-Y, Li C, Lee J, Lee S-B, Na HS (2012) Chronically relapsing pruritic dermatitis in the rats treated as neonate with capsaicin; a potential rat model of human atopic dermatitis. J Dermatol Sci 67:111–119
Beck LA, Cork MJ, Amagai M, de Benedetto A, Kabashima K, Hamilton JD, Rossi AB (2022) Type 2 inflammation contributes to skin barrier dysfunction in atopic dermatitis. JID Innov 2:100131
PubMed PubMed Central Google Scholar
Berdyshev E, Goleva E, Bronova I, Dyjack N, Rios C, Jung J, Taylor P, Jeong M, Hall CF, Richers BN (2018) Lipid abnormalities in atopic skin are driven by type 2 cytokines. JCI Insight. https://doi.org/10.1172/jci.insight.98006
PubMed PubMed Central Google Scholar
Bertino L, Guarneri F, Cannavò SP, Casciaro M, Pioggia G, Gangemi S (2020) Oxidative stress and atopic dermatitis. Antioxidants 9:196
CAS PubMed PubMed Central Google Scholar
Bieber T (2022) Atopic dermatitis: an expanding therapeutic pipeline for a complex disease. Nat Rev Drug Discov 21:21–40
Bin L, Leung DY (2016) Genetic and epigenetic studies of atopic dermatitis. Allergy Asthma Clin Immunol 12:1–14
Bissonnette R, Pavel AB, Diaz A, Werth JL, Zang C, Vranic I, Purohit VS, Zielinski MA, Vlahos B, Estrada YD (2019) Crisaborole and atopic dermatitis skin biomarkers: an intrapatient randomized trial. J Allergy Clin Immunol 144:1274–1289
Blunder S, Rühl R, Moosbrugger-Martinz V, Krimmel C, Geisler A, Zhu H, Crumrine D, Elias PM, Gruber R, Schmuth M (2017) Alterations in epidermal eicosanoid metabolism contribute to inflammation and impaired late differentiation in FLG-mutated atopic dermatitis. J Invest Dermatol 137:706–715
Borkowski AW (2014) The pattern recognition receptor toll-like receptor 3 regulates skin barrier homeostasis. University of California, San Diego
Borkowski AW, Park K, Uchida Y, Gallo RL (2013) Activation of TLR3 in keratinocytes increases expression of genes involved in formation of the epidermis, lipid accumulation, and epidermal organelles. J Invest Dermatol 133:2031–2040
CAS PubMed PubMed Central Google Scholar
Brandt EB, Sivaprasad U (2011) Th2 cytokines and atopic dermatitis. J Clin Cell Immunol 2:110
Butala S, Paller AS (2022) Optimizing topical management of atopic dermatitis. Ann Allergy Asthma Immunol 128:488–504
Cameron S, Donnelly A, Broderick C, Arichi T, Bartsch U, Dazzan P, Elberling J, Godfrey E, Gringras P, Heathcote LC (2024) Mind and skin: exploring the links between inflammation, sleep disturbance and neurocognitive function in patients with atopic dermatitis. Allergy 79:26–36
Carson CG, Rasmussen MA, Thyssen JP, Menné T, Bisgaard H (2012) Clinical presentation of atopic dermatitis by filaggrin gene mutation status during the first 7 years of life in a prospective cohort study. PLoS ONE 7:e48678
CAS PubMed PubMed Central Google Scholar
Chalayer E, Gramont B, Zekre F, Goguyer-Deschaumes R, Waeckel L, Grange L, Paul S, Chung AW, Killian M (2022) Fc receptors gone wrong: a comprehensive review of their roles in autoimmune and inflammatory diseases. Autoimmun Rev 21:103016
Chen H, Zhang J, He Y, Lv Z, Liang Z, Chen J, Li P, Liu J, Yang H, Tao A (2022a) Exploring the role of Staphylococcus aureus in inflammatory diseases. Toxins 14:464
CAS PubMed PubMed Central Google Scholar
Chen L, Lin S-X, Agha-Majzoub R, Overbergh L, Mathieu C, Chan LS (2006) CCL27 is a critical factor for the development of atopic dermatitis in the keratin-14 IL-4 transgenic mouse model. Int Immunol 18:1233–1242
Chen L, Martinez O, Overbergh L, Mathieu C, Prabhakar B, Chan L (2004) Early up-regulation of Th2 cytokines and late surge of Th1 cytokines in an atopic dermatitis model. Clin Exp Immunol 138:375–387
CAS PubMed PubMed Central Google Scholar
Chen M, Wang R, Wang T (2024a) Gut microbiota and skin pathologies: mechanism of the gut-skin axis in atopic dermatitis and psoriasis. Int Immunopharmacol 141:112658
Chen S, Li C, Tu Z, Cai T, Zhang X, Wang L, Tian R, Huang J, Gong Y, Yang X (2024b) Off-label use of Baricitinib improves moderate and severe atopic dermatitis in China through inhibiting MAPK and PI3K/Akt/mTOR pathway via targeting JAK-STAT signaling of CD4+ cells. Front Pharmacol 15:1324892
CAS PubMed PubMed Central Google Scholar
Chen W-C, Liu Y-B, Liu W-F, Zhou Y-Y, He H-F, Lin S (2020) Neuropeptide Y is an immunomodulatory factor: direct and indirect. Front Immunol 11:580378
CAS PubMed PubMed Central Google Scholar
Chen W-Y, Chen S-C, Hsu S-Y, Lin Y-A, Shih C-M, Huang C-Y, Wang K-H, Lee A-W (2022b) Annoying psoriasis and atopic dermatitis: a narrative review. Int J Mol Sci 23:4898
CAS PubMed PubMed Central Google Scholar
Chen Y, Xian Y-F, Loo S, Chan WY, Liu L, Lin Z-X (2021) Anti-atopic dermatitis effects of dictamni cortex: studies on in vitro and in vivo experimental models. Phytomedicine 82:153453
Chen Z-F (2021) A neuropeptide code for itch. Nat Rev Neurosci 22:758–776
CAS PubMed PubMed Central Google Scholar
Chieosilapatham P, Kiatsurayanon C, Umehara Y, Trujillo-Paez J, Peng G, Yue H, Nguyen L, Niyonsaba F (2021) Keratinocytes: innate immune cells in atopic dermatitis. Clin Exp Immunol 204:296–309
CAS PubMed PubMed Central Google Scholar
Cho HR, Uhm YK, Kim HJ, Ban JY, Chung JH, Yim SV, Choi BK, Lee MH (2011) Glutathione S-transferase M1 (GSTM1) polymorphism is associated with atopic dermatitis susceptibility in a Korean population. Int J Immunogenet 38:145–150
Choi JH, Lee GH, Jin SW, Kim JY, Hwang YP, Han EH, Kim YH, Jeong HG (2021) Impressic acid ameliorates atopic dermatitis-like skin lesions by inhibiting ERK1/2-mediated phosphorylation of NF-κB and STAT1. Int J Mol Sci 22:2334
CAS PubMed PubMed Central Google Scholar
Choi W, Lee HP, Manilack P, Saysavanh V, Lee B-H, Lee S, Kim E, Cho JY (2023) Antiallergic effects of Callerya atropurpurea extract in vitro and in an in vivo atopic dermatitis model. Plants 12:860
Comments (0)